In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Katherine Kurnit. Dr. Kurnit is an Assistant Professor at the University of Chicago in the section of Gynecologic Oncology. Her research interests include developmental therapeutics and early phase clinical trials for patients with gynecologic cancers. Highlights: Although surgical practices have changed over time, there is still much debate and no consistent consensus about timing or the use of new therapies...
Mar 31, 2022•27 min
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Genevieve Bouchard-Fortier. Dr. Bouchard-Fortier is an assistant professor in the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology at the University of Toronto and a member of the Division of Gynecologic Oncology at the University Health Network/Sinai Health Systems. Her research is focused on improving the quality of care of gynecologic oncology patients as well as developing q...
Mar 30, 2022•41 min
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. David M. Gershenson to discuss the use of trametinib in low-grade serous cancer. Dr. Gershenson is Professor and former Chair of the Department of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center. His major focus is on the clinical and translational research of rare ovarian cancers. Highlights: Trametinib represents a new standard for the treatment of recurre...
Mar 28, 2022•42 min
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Rene Pareja, a gynecologist-oncologist at Astorga Oncology Clinic in Medellín and the National Cancer Institute in Bogotá, Colombia. Dr. Pareja is a reviewer for more than 20 specialty journals, an Associate Editor for IJGC, and a member of the board of directors of the International Gynecological Cancer Society (IGCS). He is the author of nine book chapters and more than 70 publications in peer-reviewed jour...
Mar 21, 2022•54 min
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Alex Melamed to discuss neoadjuvant versus primary surgery. Alex Melamed is a gynecologist oncologist and a health services researcher at Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian Columbia Irving Medical Center. Highlights: - The emergence of evidence supporting non-inferiority of neoadjuvant chemotherapy (NACT) compared with primary surgery for advance ovarian ca...
Mar 10, 2022•39 min
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. David Gaffney, Dr. Carien Creutzberg, and Dr. Anuja Jhingran to discuss this month's special issue on radiation oncology. Dr. Gaffney, MD, PhD, Senior Director of Clinical Research, is Professor and Vice-Chair of the University of Utah (U of U) Department of Radiation Oncology. Dr. Gaffney is a distinguished clinician and a long-standing leader in clinical research, and he is also a past president of the Amer...
Mar 07, 2022•42 min
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Robert Coleman to discuss TV in Advanced or Recurrent Cervical Cancer. HIGHLIGHTS: Drug development in cervix cancer has undergone a renaissance in recent years with the identification of novel antibody drug conjugates (ADC) and immunotherapy measurably impacting patient survivorship. Tisotumab vedotin (TV) is an ADC targeting tumor expression of tissue factor delivering the cytotoxic warhead MMAE. InnovaTV ...
Mar 01, 2022•41 min
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Andreas Obermair and Monika Janda to discuss the FeMMe trial. Highlights: feMMe was a randomised phase 2 trial testing LNG-IUD alone or in combination with a weight loss intervention or metformin for endometrial hyperplasia with atypia or stage 1 endometrial cancer. Overall complete pathological response at 6 month was 61%. Women with endometrial hyperplasia with atypia responded much better than women with...
Feb 21, 2022•49 min
In this episode of the IJGC Podcast, Editorial Fellow Felix Boria discusses the contents of the February issue of IJGC in Spanish.
Feb 11, 2022•17 min
In this episode of the IJGC Podcast, Editorial Fellows Floriane Jochum and Natalie Medley discuss the contents of the February issue of IJGC in English.
Feb 11, 2022•16 min
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. David M. Gershenson to discuss legends in gynecologic oncology. Dr. Gershenson is Professor and former Chair of the Department of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center. His major focus is on the clinical and translational research or rare ovarian cancers. Highlights: Mentoring is an essential component of a successful career in gynecologic oncolog...
Feb 08, 2022•30 min
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Enrique Chacón and Luis Chiva to discuss the possible protective role of conization.
Feb 04, 2022•35 min
In this episode of the IJGC Podcast, former Editorial Fellow Irina Tsibulak discusses the contents of the January issue of IJGC in Russian.
Feb 03, 2022•17 min
In this episode of the IJGC Podcast, former Editorial Fellow Irina Tsibulak discusses the contents of the January issue of IJGC in Russian.
Jan 31, 2022•14 min
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Nicole Concin to discuss the article European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma. Dr. Concin is a gynaecological oncologist, ESGO president, Co-Chair of ENGOT Early Drug Development Network, and Professor at Medical University of Innsbruck, Innsbruck Austria & Kliniken Essen-Mitte, Essen, Germany. Related Link: https://ijgc.bmj.com/co...
Jan 27, 2022•46 min
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Prof. Philipp Harter to discuss The DESKTOP III Trial. Prof. Harter is the director of the Department of Gynecology & Gynecologic Oncology at Kliniken Essen-Mitte in Essen, Germany, and the chair of the AGO Study Group. Highlights: -Role of surgery for relapsed ovarian cancer is under debate -DESKTOP III has shown a significant benefit regarding PFS and OS by secondary cytoreduction -The data, interpretation...
Jan 21, 2022•41 min
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Gloria Salvo and Dr. Rene Pareja to discuss IRTA: Open vs MIS Radical Trachelectomy. Dr. Salvo was trained as a gynecologist in Hospital Italiano de Buenos Aires, Argentina and works as a Clinical Reviewer/Data Abstractor of the Neuroendocrine Cervical Tumor Registry (NeCTuR) at MD Anderson Cancer Center. She has published several articles in cervical cancer including sentinel lymph node mapping and fertilit...
Jan 14, 2022•40 min
In this episode of the IJGC Podcast, Editorial Fellow Felix Boria discusses the contents of the January issue of IJGC in Spanish.
Jan 13, 2022•17 min
In this episode of the IJGC Podcast, Editorial Fellows Dimitrios Nasioudis and Floriane Jochum discuss the contents of the January issue of IJGC in English.
Jan 13, 2022•16 min
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Gabriela Benjamin to discuss a patient’s perspective on ovarian cancer. Gabriela Gesteira Benjamin 38 years old and was born in Brazil and grew up in Miami. She attended Columbia University where she studied engineering. She has worked in finance for the past 15 years and is currently a portfolio manager at Blackrock. She is the daughter of Roberto Benjamin and late Fatima Gesteira and sister to Joana Benjamin a...
Jan 07, 2022•34 min
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Andreina Fernandes to discuss HPV-independent Cervical Cancers. Dr. Fernandes is a Molecular Biologist, Doctor of Science, and author of “Human papillomavirus-independent cervical cancer,” the Lead Article for the January 2022 issue of IJGC. Dr. Fernandes is a Researcher of the Molecular Genetics Laboratory at the Institute of Oncology and Hematology, and Professor of the Faculty of Dentistry, at Universidad...
Dec 27, 2021•29 min
In this rebroadcasted episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Sarah Ferguson. Dr. Ferguson is a Professor in the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology at the University of Toronto and a member of the Division of Gynecologic Oncology at University Health Network/Sinai Health Systems. She is the Director of Research for the Division of Gynecologic Oncology at Princess Margaret Cancer. Dr. Ferguson completed her resi...
Dec 10, 2021•30 min
In this rebroadcasted episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Nicole Concin to discuss the ESGO-ESTRO-ESP Endometrial Cancer Guidelines (ijgc.bmj.com/content/early/2020…8/ijgc-2020-002230)
Dec 10, 2021•43 min
In this rebroadcasted episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Professor Christina Fotopoulou to discuss the ESGO Guidelines on Perioperative Management Ovarian Cancer. Professor Fotopoulou is the lead author of “European Society of Gynaecological Oncology guidelines for the peri-operative management of patients with ovarian cancer,” which is the Lead Article of IJGC’s September 2021 issue. Professor Fotopoulou works at the Department of Surgery and Cancer at ...
Dec 10, 2021•50 min
In this episode of the IJGC Podcast, Editorial Fellows Emma Allanson and Cecilia Darin discuss the contents of the December issue of IJGC in English.
Dec 06, 2021•12 min
In this episode of the IJGC Podcast, Editorial Fellows Natalia Rodriguez and Erick Estrada discuss the contents of the December issue of IJGC in Spanish.
Dec 03, 2021•13 min
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Jennifer Chae-Kim. Dr. Chae-Kim is the author of Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis, which is the Lead Article of IJGC’s December 2021 issue. Dr. Chae-Kim is in her last year of OB/GYN residency at BSW-Temple, and will be pursuing her interests in fertility preservation and fellowship ...
Dec 02, 2021•29 min
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Professor Andreas du Bois. Professor du Bois completed his medical degree in 1987 at the University of Freiburg, Germany. He subsequently trained in general surgery at Krankenhaus Wolfach Personalwohnheim and gynaecology and obstetrics at the University of Freiburg, leading to his registration as Fellow for Gynaecology and Obstetrics in 1993. In 1993, Prof. du Bois became a Consultant in the Department of Gynaec...
Nov 24, 2021•40 min
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Jason Wright to discuss SLN in endometrial atypical hyperplasia. Dr. Wright is the Sol Goldman Associate Professor and Chief of the Division of Gynecologic Oncology at Columbia University. Highlights: -Performance of sentinel lymph node mapping is increasing in women undergoing hysterectomy for complex atypical endometrial hyperplasia. -Sentinel lymph node mapping in women with atypical endometrial hyperplas...
Nov 19, 2021•30 min
In this episode of the IJGC Podcast, Editorial Fellow Irina Tsibulak discusses the contents of the November issue of IJGC in Russian.
Nov 15, 2021•13 min
